Development and validation of the Nightingale Symptom Assessment Scale (N-SAS) and predictors of the quality of life of the cancer patients in Turkey


Can G. , Aydiner A.

EUROPEAN JOURNAL OF ONCOLOGY NURSING, vol.15, no.1, pp.3-11, 2011 (Journal Indexed in SCI) identifier identifier identifier

  • Publication Type: Article / Article
  • Volume: 15 Issue: 1
  • Publication Date: 2011
  • Doi Number: 10.1016/j.ejon.2009.10.010
  • Title of Journal : EUROPEAN JOURNAL OF ONCOLOGY NURSING
  • Page Numbers: pp.3-11

Abstract

Purpose: Treatment-related side effects have an adverse impact on the health-related quality of life (HRQoL) of cancer patients undergoing chemotherapy. This study is a description of the validity and responsiveness demonstrated by a new cancer and cancer treatment-specific symptom scale - the Nightingale Symptom Assessment Scale (N-SAS) - which was developed and validated to address the QoL of Turkish cancer patients.